Idiopathic dilated cardiomyopathy in children: a single medical center's experience

Ken-Pen Weng1, Chu-Chuan Lin, Shi-Huei Huang

  • 1Department of Pediatrics, Kaohsiung Veterans General Hospital, Taiwan.

Insights

Idiopathic dilated cardiomyopathy (DCM) in children has a poor prognosis, with many succumbing to heart failure while awaiting transplants. Arrhythmia and low ejection fraction predict poor outcomes in pediatric DCM patients.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Research
  • Transplantation Medicine

Background:

  • Idiopathic dilated cardiomyopathy (DCM) presents a significant challenge in pediatric care.
  • Limited donor availability in Taiwan exacerbates poor prognoses for children with DCM.

Purpose of the Study:

  • To review the clinical experience with pediatric idiopathic DCM.
  • To identify prognostic factors influencing outcomes in affected children.

Main Methods:

  • Retrospective analysis of 18 pediatric idiopathic DCM patients (1990-2004).
  • Patients categorized into survival and mortality groups.
  • Comparison of clinical and laboratory data between groups.

Main Results:

  • 13 out of 18 pediatric patients died, primarily from heart failure while awaiting transplantation.
  • Cumulative survival rates were 50% at 1 year and 28% at 4 years.
  • Arrhythmia and reduced left ventricular ejection fraction were identified as predictors of poor outcomes.

Conclusions:

  • Pediatric idiopathic DCM carries a generally poor prognosis.
  • The scarcity of organ donors significantly contributes to mortality in pediatric transplant candidates.
  • Increased organ donation is crucial to improve survival rates for children with DCM awaiting transplantation.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...